<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00841683132721</udiDi>
    <basicUdiDi>008416831280R-1DL</basicUdiDi>
    <tradeName>Mammaglobin (31A5) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>280R-17</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.878Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683132745</udiDi>
    <basicUdiDi>008416831280R-1DL</basicUdiDi>
    <tradeName>Mammaglobin (31A5) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>280R-18</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.857Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683132820</udiDi>
    <basicUdiDi>008416831281M-8DG</basicUdiDi>
    <tradeName>MART-1 (Melan A) (A103) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>281M-84</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.834Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683132837</udiDi>
    <basicUdiDi>008416831281M-8DG</basicUdiDi>
    <tradeName>MART-1 (Melan A) (A103) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>281M-85</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.812Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683132844</udiDi>
    <basicUdiDi>008416831281M-8DG</basicUdiDi>
    <tradeName>MART-1 (Melan A) (A103) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>281M-86</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.789Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683132851</udiDi>
    <basicUdiDi>008416831281M-8DG</basicUdiDi>
    <tradeName>MART-1 (Melan A) (A103) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>281M-87</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.768Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683132868</udiDi>
    <basicUdiDi>008416831281M-8DG</basicUdiDi>
    <tradeName>MART-1 (Melan A) (A103) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>281M-88</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.749Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683132943</udiDi>
    <basicUdiDi>008416831282M-9DR</basicUdiDi>
    <tradeName>HMB-45 (HMB-45) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>282M-94</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.735Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683132950</udiDi>
    <basicUdiDi>008416831282M-9DR</basicUdiDi>
    <tradeName>HMB-45 (HMB-45) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>282M-95</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.721Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683132967</udiDi>
    <basicUdiDi>008416831282M-9DR</basicUdiDi>
    <tradeName>HMB-45 (HMB-45) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>282M-96</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.711Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683132974</udiDi>
    <basicUdiDi>008416831282M-9DR</basicUdiDi>
    <tradeName>HMB-45 (HMB-45) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>282M-97</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.700Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683132981</udiDi>
    <basicUdiDi>008416831282M-9DR</basicUdiDi>
    <tradeName>HMB-45 (HMB-45) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>282M-98</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.688Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683132998</udiDi>
    <basicUdiDi>008416831283M-1DG</basicUdiDi>
    <tradeName>HBME-1 (HBME-1) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>283M-14</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.664Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683133001</udiDi>
    <basicUdiDi>008416831283M-1DG</basicUdiDi>
    <tradeName>HBME-1 (HBME-1) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>283M-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.639Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683133018</udiDi>
    <basicUdiDi>008416831283M-1DG</basicUdiDi>
    <tradeName>HBME-1 (HBME-1) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>283M-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.614Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683133025</udiDi>
    <basicUdiDi>008416831283M-1DG</basicUdiDi>
    <tradeName>HBME-1 (HBME-1) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>283M-17</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.593Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683133032</udiDi>
    <basicUdiDi>008416831283M-1DG</basicUdiDi>
    <tradeName>HBME-1 (HBME-1) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>283M-18</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.574Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683134190</udiDi>
    <basicUdiDi>008416831298M-1EW</basicUdiDi>
    <tradeName>Myosin, Smooth Muscle (SMMS-1) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>298M-14</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.554Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683134206</udiDi>
    <basicUdiDi>008416831298M-1EW</basicUdiDi>
    <tradeName>Myosin, Smooth Muscle (SMMS-1) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>298M-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.532Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683134213</udiDi>
    <basicUdiDi>008416831298M-1EW</basicUdiDi>
    <tradeName>Myosin, Smooth Muscle (SMMS-1) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>298M-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T23:29:45.510Z</lastUpdated>
  </row>
</eudamedExport>